Clinical Trial Update: A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of HBS-301 for idiopathic hypersomnia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia

Drugs mentioned

• HBS-301

Snippet

Sponsor: Harmony Biosciences Management, Inc. | Conditions: Idiopathic Hypersomnia | Phase 3 | Status: RECRUITING